Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Innogest Capital is a venture capital firm founded in 2006 and headquartered in Italy. The firm operates from offices in Turin, Milan, Geneva, and San Francisco, managing investment funds totaling over €200 million. Innogest Capital focuses on providing capital to innovative companies, particularly in the technology and healthcare sectors. The firm has established a reputation for supporting early-stage and growth-stage companies, leveraging over 100 years of cumulative professional experience among its team members.
Since its inception, Innogest Capital has aimed to foster entrepreneurship and growth in Europe, particularly in the digital and biomedical sectors. The firm has made significant strides in promoting innovative solutions that address pressing healthcare challenges, positioning itself as a key player in the European venture capital landscape.
Innogest Capital primarily invests in the healthcare and technology sectors, targeting early-stage and growth-stage companies. The firm seeks to support innovative ventures that demonstrate global ambitions, particularly in areas such as digital health, medical technologies, and digital platforms. Innogest Capital has a strong interest in specific healthcare challenges, including cardiovascular diseases, neurological disorders, and oncology.
The firm typically invests in companies that are at the forefront of technological advancements and have the potential to make a significant impact in their respective fields. Innogest Capital's investment strategy emphasizes collaboration with startups that align with its focus on innovation and growth in Europe.
Innogest Capital has built a diverse portfolio of companies, particularly in the healthcare sector. Notable portfolio companies include:
This portfolio reflects Innogest Capital's commitment to investing in innovative solutions that address critical healthcare needs.
Claudio Giuliano: Managing Partner with extensive experience in venture capital and a focus on healthcare investments.
Stefano Molino: Partner specializing in technology investments, bringing a wealth of knowledge in scaling startups.
Hadi Abderrahim: Head of Strategy Healthcare, with expertise in healthcare innovation and market dynamics.
Hiroaki Tanaka: Head of Personalized Medicine, focusing on advancements in personalized healthcare solutions.
Marco Pinciroli: Partner with a strong background in venture capital and technology sectors.
Johann Tse: Venture Partner, contributing insights from his extensive experience in the startup ecosystem.
Simona Roggero: Venture Partner with a focus on supporting innovative healthcare startups.
Riccardo Palmisano: Venture Partner, bringing expertise in business development and strategic growth.
To pitch Innogest Capital, founders should send an email to info@innogestcapital.com. A detailed pitch deck is recommended, including information on the business model, market opportunity, and team background. Response times may vary, but founders can expect to hear back within a few weeks.
Innogest Capital has initiated the Italian Patents Competition, which offers a €250,000 investment for projects based on patents developed in Italy, particularly in the life sciences and digital sectors. This program aims to promote economic valuation and international competitiveness of patents.
Innogest Capital has been active in the venture capital space, particularly in supporting innovative healthcare startups. Recently, the firm participated in the Italian Patents Competition, which offers a €250,000 investment for projects based on patents developed in Italy. This initiative aims to enhance the international competitiveness of Italian research.
Additionally, Innogest Capital continues to expand its portfolio, focusing on companies that address critical healthcare challenges. Their commitment to fostering innovation in Europe remains a key aspect of their investment strategy.
What are Innogest Capital's investment criteria?
Innogest Capital focuses on early-stage and growth-stage companies primarily in the healthcare and technology sectors. The firm looks for innovative solutions that have the potential for significant impact and global reach.
How can I pitch to Innogest Capital?
Founders can reach out to Innogest Capital via email at info@innogestcapital.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes Innogest Capital different from other investors?
Innogest Capital distinguishes itself through its strong focus on healthcare and technology sectors, combined with a deep understanding of the European market. The firm's team has over 100 years of cumulative experience, which enhances its ability to support portfolio companies effectively.
What is the geographic scope of Innogest Capital's investments?
The firm primarily invests in companies located in Europe, with a particular emphasis on those that demonstrate innovative approaches in healthcare and technology.
What is the typical check size for investments?
While specific check sizes are not disclosed, Innogest Capital targets early-stage and growth-stage investments, which typically range from seed funding to larger growth equity rounds.
What kind of post-investment support does Innogest Capital provide?
Innogest Capital actively engages with its portfolio companies, offering mentorship, strategic guidance, and access to its extensive network to help drive growth and innovation.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.